These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2398880)

  • 21. Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status.
    Sulkes A; Fuks Z; Gordon A; Gross J
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):19-23. PubMed ID: 6537912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.
    Chapurlat RD; Garnero P; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 2000 Sep; 15(9):1835-41. PubMed ID: 10977003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of N-terminal pro B-type natriuretic peptide and sex hormone-binding globulin in non-obese peri- and postmenopausal women.
    Yasui T; Matsui S; Saijo A; Kaji T; Yamamoto S; Uemura H; Matsuzaki T; Irahara M
    Clin Chim Acta; 2010 Feb; 411(3-4):280-4. PubMed ID: 19945451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
    Enriori CL; Orsini W; del Carmen Cremona M; Etkin AE; Cardillo LR; Reforzo-Membrives J
    Gynecol Oncol; 1986 Jan; 23(1):77-86. PubMed ID: 3943755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
    Costantino L; Catalano MG; Frairia R; Carmazzi CM; Barbero M; Coluccia C; Donadio M; Genta F; Drogo M; Boccuzzi G; Fortunati N
    Breast Cancer Res Treat; 2009 Apr; 114(3):449-56. PubMed ID: 18437557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
    Murayama Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency?
    Meyer S; Brumm C; Stegner HE; Sinnecker GH
    Exp Clin Endocrinol; 1994; 102(4):334-40. PubMed ID: 7529185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.
    Fortunati N; Catalano MG; Boccuzzi G; Frairia R
    Mol Cell Endocrinol; 2010 Mar; 316(1):86-92. PubMed ID: 19770023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.